GAPS connects ankylosing spondylitis with the gut wall, microbial balance and immune responses that affect the joints. The 2020 book describes those connections together, rather than presenting the spine as an isolated problem.[1]
The original research cited in the book is worth reading carefully. A study of intestinal tissue, a measurement of antibodies and a treatment trial answer different questions. Understanding that difference makes the gut–joint discussion more useful, without asking one study to explain everything.
The Gut-Wall Account
Dr. Natasha describes abnormal gut flora affecting the lining and its tight junctions. In her account, a damaged barrier allows incompletely digested food and microbial products to reach the body, creating a continuing immune workload.[1][2]
The ankylosing-spondylitis entry applies that framework to chronic inflammation and sclerotic joint changes. It is the author’s explanation of how a gut problem can be connected with symptoms elsewhere. It does not make every food reaction a measurement of gut permeability.
What the Intestinal-Biopsy Study Found
Ciccia and colleagues studied ileal biopsies from 50 HLA-B27-positive people with ankylosing spondylitis and 20 controls. They found adherent or invasive bacteria in 35 of the 50 patients, alongside changes in barrier proteins and findings connecting the gut with circulating bacterial products.[3]
That is direct patient research relevant to the gut–joint connection. The cultured bacteria described included E. coli and Prevotella; the paper is not evidence that every case involved Klebsiella. Its antibiotic experiment was in HLA-B27 transgenic rats, separate from the human biopsy work.[3]
The study investigated barriers and immune responses. It did not test the GAPS Diet or show that one person’s joint changes reverse after a particular food is added. Those distinctions keep its findings useful rather than overstating them.
Klebsiella and the Immune Response
The book describes Klebsiella pneumoniae as a common gut microbe associated with ankylosing spondylitis and an active immune response.[1] One of its cited original studies examined jejunal fluid from 19 people with ankylosing spondylitis, 14 with rheumatoid arthritis and 22 healthy controls.[4]
The researchers measured antibodies to several enteric bacteria. They found increased antibody responses, particularly to Klebsiella, in the ankylosing-spondylitis group.[4] An antibody finding supports an immune association; it is not the same as culturing an infection or diagnosing overgrowth from a stool test.
Together, these studies give concrete research context for the book’s microbial discussion. They do not establish one universal bacterial cause or tell an individual which antibiotic or probiotic to use. The support guide explains the book and FAQ’s separate treatment discussion.
How GAPS Interprets Autoimmunity
The immune chapter describes antibodies and inflammation as responses to substances and tissues that have become altered or contaminated. Dr. Natasha argues that the immune system is trying to clear a problem, rather than attacking without a reason.[2]
That interpretation is central to why GAPS focuses on nourishing the body, supporting the gut wall and reducing the exposures it discusses. An immune response measured in a research study is still different from a diagnosis of what is driving one person’s symptoms.
For the wider chapter, read autoimmunity and the gut. That explanation should not be used to stop prescribed immune treatment or to assume that every positive antibody result has the same meaning.
Collagen and Structural Change
The book describes collagen as a major structural protein in joints, ligaments, fascia and other tissues. Its collagen account proposes that altered or contaminated fibers attract immune activity and may be cleared or dismantled.[2] The ankylosing-spondylitis entry directs readers to that discussion.[1]
This explains why connective-tissue nourishment appears in the food advice. It does not mean that loose joints, bruising and spinal fusion are interchangeable findings. Nor does it establish that rebuilding tissue through food will reverse already fused bone.
The back-pain and collagen guide explains the related connective-tissue account. Keep an actual imaging report and diagnosis with the discussion rather than replacing them with the word “collagen.”
Environmental and Medicine Examples Have Their Own Scope
The same chapter discusses environmental exposures, including a proposed glyphosate–protein mechanism. It also uses drug-induced lupus as an example of medicine-related autoimmunity, and discusses smoke, cosmetics and insecticides in relation to rheumatoid arthritis.[2]
Those examples explain the author’s broader view of exposure. They are not findings that each substance caused ankylosing spondylitis in a particular reader. The glyphosate account is a proposed mechanism, not a measured substitution in that person’s spinal collagen. An association discussed for rheumatoid arthritis should not be silently relabeled as an ankylosing-spondylitis study.
Bring a real exposure or medicine question into care with its name and timing. Do not turn the chapter’s examples into a reason to stop a prescribed medicine on your own.
Put Each Kind of Evidence in Its Place
| What You Are Reading | What It Addresses |
|---|---|
| The GAPS condition entry | The author’s gut, immune and long-term support framework. |
| The 2017 biopsy study | Intestinal bacteria, barriers and immune findings in its patient group, with separate laboratory and rat experiments. |
| The 1997 antibody study | Mucosal immune responses, not a stool-overgrowth diagnosis or an eradication trial. |
| Your own history and tests | Questions about your actual symptoms and care, interpreted in their clinical context. |
The history guide helps make those personal questions specific. The overview brings the wider reading together. For a place to collect appointment questions, look for the Care Team Log through the WFLI shop.
References
- Campbell-McBride, N. Gut and Physiology Syndrome (2020), “Ankylosing Spondylitis,” pp. 408–409.
- Campbell-McBride, N. Gut and Physiology Syndrome (2020), immune-system chapter, autoimmunity, collagen and environmental/medicine examples.
- Ciccia F, et al. Dysbiosis and Zonulin Upregulation Alter Gut Epithelial and Vascular Barriers in Patients With Ankylosing Spondylitis. Ann Rheum Dis. 2017;76:1123–1132. doi:10.1136/annrheumdis-2016-210000. Author’s accepted manuscript.
- Mäki-Ikola O, et al. Enhanced Jejunal Production of Antibodies to Klebsiella and Other Enterobacteria in Patients With Ankylosing Spondylitis and Rheumatoid Arthritis. Ann Rheum Dis. 1997;56:421–425. doi:10.1136/ard.56.7.421.
Leave a comment